Literature DB >> 10694200

[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Y Dumont1, R Quirion.   

Abstract

GR231118 (also known as 1229U91 and GW1229), a purported Y(1) antagonist and Y(4) agonist was radiolabelled using the chloramine T method. [(125)I]-GR231118 binding reached equilibrium within 10 min at room temperature and remained stable for at least 4 h. Saturation binding experiments showed that [(125)I]-GR231118 binds with very high affinity (K(d) of 0.09 - 0.24 nM) in transfected HEK293 cells with the rat Y(1) and Y(4) receptor cDNA and in rat brain membrane homogenates. No specific binding sites could be detected in HEK293 cells transfected with the rat Y(2) or Y(5) receptor cDNA demonstrating the absence of significant affinity of GR231118 for these two receptor classes. Competition binding experiments revealed that specific [(125)I]-GR231118 binding in rat brain homogenates is most similar to that observed in HEK293 cells transfected with the rat Y(1), but not rat Y(4), receptor cDNA. Autoradiographic studies demonstrated that [(125)I]-GR231118 binding sites were fully inhibited by the Y(1) antagonist BIBO3304 in most areas of the rat brain. Interestingly, high percentage of [(125)I]-GR231118/BIBO3304-insensitive binding sites were detected in few areas. These [(125)I]-GR231118/BIBO3304-insensitive binding sites likely represent labelling to the Y(4) receptor subtype. In summary, [(125)I]-GR231118 is a new radiolabelled probe to investigate the Y(1) and Y(4) receptors; its major advantage being its high affinity. Using highly selective Y(1) antagonists such as BIBO3304 or BIBP3226 it is possible to block the binding of [(125)I]-GR231118 to the Y(1) receptor allowing for the characterization and visualization of the purported Y(4) subtype. British Journal of Pharmacology (2000) 129, 37 - 46

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694200      PMCID: PMC1621114          DOI: 10.1038/sj.bjp.0702983

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  73 in total

1.  Regional distribution of Y-receptor subtype mRNAs in rat brain.

Authors:  R M Parker; H Herzog
Journal:  Eur J Neurosci       Date:  1999-04       Impact factor: 3.386

2.  Discrete distribution of the neuropeptide Y Y5 receptor gene in the human brain: an in situ hybridization study.

Authors:  D Jacques; Y Tong; S H Shen; R Quirion
Journal:  Brain Res Mol Brain Res       Date:  1998-10-30

Review 3.  Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships.

Authors:  R Quirion; J C Martel; Y Dumont; A Cadieux; F Jolicoeur; S St-Pierre; A Fournier
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat.

Authors:  A Burkhoff; D L Linemeyer; J A Salon
Journal:  Brain Res Mol Brain Res       Date:  1998-01

5.  Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum.

Authors:  L Caberlotto; K Fuxe; G Sedvall; Y L Hurd
Journal:  Eur J Neurosci       Date:  1997-06       Impact factor: 3.386

6.  [125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors.

Authors:  D R Gehlert; D A Schober; S L Gackenheimer; L Beavers; R Gadski; I Lundell; D Larhammar
Journal:  Peptides       Date:  1997       Impact factor: 3.750

7.  Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.

Authors:  C Wahlestedt; N Yanaihara; R Håkanson
Journal:  Regul Pept       Date:  1986-02

8.  The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.

Authors:  D A Schober; A M Van Abbema; D L Smiley; R F Bruns; D R Gehlert
Journal:  Peptides       Date:  1998       Impact factor: 3.750

9.  Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.

Authors:  Y Dumont; D Jacques; P Bouchard; R Quirion
Journal:  J Comp Neurol       Date:  1998-12-21       Impact factor: 3.215

Review 10.  Effects of neuropeptide Y on the electrical properties of neurons.

Authors:  W F Colmers; D Bleakman
Journal:  Trends Neurosci       Date:  1994-09       Impact factor: 13.837

View more
  8 in total

1.  BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.

Authors:  Y Dumont; A Cadieux; H Doods; L H Pheng; R Abounader; E Hamel; D Jacques; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells.

Authors:  Leng Hong Pheng; Yvan Dumont; Alain Fournier; Jean-Guy Chabot; Alain Beaudet; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

3.  BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.

Authors:  Yvan Dumont; Pierrette Gaudreau; Manuela Mazzuferi; Daniel Langlois; Jean-Guy Chabot; Alain Fournier; Michele Simonato; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

4.  Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226.

Authors:  C Mollereau; C Gouardères; Y Dumont; M Kotani; M Detheux; H Doods; M Parmentier; R Quirion; J M Zajac
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

5.  Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines.

Authors:  H M Cox; I R Tough; D W Zandvliet; N D Holliday
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.

Authors:  A Thorsell; M Michalkiewicz; Y Dumont; R Quirion; L Caberlotto; R Rimondini; A A Mathé; M Heilig
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema.

Authors:  Yvan Dumont; Emmanuel Moyse; Alain Fournier; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2007-09-18       Impact factor: 3.444

8.  Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.

Authors:  Yvan Dumont; Mira Thakur; Annette Beck-Sickinger; Alain Fournier; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.